NORTHERN TRUST CORP - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,620,709
-9.2%
520,496
+0.5%
0.00%0.0%
Q2 2023$7,290,132
-6.7%
517,765
+2.4%
0.00%
-50.0%
Q1 2023$7,812,617
+8.1%
505,671
+14.7%
0.00%0.0%
Q4 2022$7,225,794
-9.7%
440,866
+1.9%
0.00%0.0%
Q3 2022$8,004,000
+40.4%
432,660
-0.2%
0.00%
+100.0%
Q2 2022$5,700,000
+53.3%
433,476
+8.1%
0.00%0.0%
Q1 2022$3,718,000
-7.4%
401,027
-2.4%
0.00%0.0%
Q4 2021$4,013,000
-70.5%
410,700
+2.4%
0.00%
-50.0%
Q3 2021$13,625,000
-12.3%
400,960
-5.5%
0.00%
-33.3%
Q2 2021$15,536,000
-21.1%
424,339
-3.4%
0.00%
-25.0%
Q1 2021$19,694,000
-24.4%
439,191
-3.7%
0.00%
-20.0%
Q4 2020$26,035,000
+10.8%
456,199
-0.4%
0.01%0.0%
Q3 2020$23,487,000
-12.3%
457,829
+2.1%
0.01%
-16.7%
Q2 2020$26,770,000
+135.2%
448,270
+62.2%
0.01%
+100.0%
Q1 2020$11,381,000
-29.5%
276,442
+6.5%
0.00%
-25.0%
Q4 2019$16,150,000
+92.9%
259,480
+5.2%
0.00%
+100.0%
Q3 2019$8,371,000
+202.5%
246,648
+101.1%
0.00%
+100.0%
Q2 2019$2,767,000
-11.5%
122,669
-8.9%
0.00%0.0%
Q1 2019$3,126,000
+7.1%
134,689
-3.1%
0.00%0.0%
Q4 2018$2,918,000
-46.2%
138,994
-0.8%
0.00%0.0%
Q3 2018$5,427,000
+20.1%
140,169
+22.1%
0.00%0.0%
Q2 2018$4,518,000
+166.1%
114,826
+35.5%
0.00%
Q1 2018$1,698,000
-0.2%
84,732
+12.8%
0.00%
Q4 2017$1,702,00075,0920.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders